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Abstract
Objective: The objective of this study is to assess differences in self-described
goals for treating symptomatic pelvic organ prolapse for women that choose
surgery compared to women who choose pessary.
Methods: Women who had symptomatic stage 2 prolapse or greater presenting
for care of pelvic organ prolapse to the Urogynecology Clinic at the University of
New Mexico were recruited. These patients listed up to three goals they had of
their treatment and rated the goals from 0 to 10, with 10 being the most
important. In addition, patients completed the short forms of the established
Pelvic Floor Distress Inventory (PFDI-20), short form of the Pelvic Organ
Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12) and the Body
Image Scale (BIS). The goals by the patients were then categorized into three
categories. Each of the listed goals was categorized based on a consensus of 6
providers.
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Results: There were no significant differences between the two groups’ baseline
characteristics. Patients’ goals were categorized into three categories by a
consensus of the providers. There was a significant difference in pessary and
surgery patient ratings of goals only for one of the goal categories (p<0.05).
Conclusion: Patient goals for treatment do not appear to differ.
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Preface
We do what we do for the patients and hope to achieve our goals as a physician
not only as medically indicated but more importantly patient goals. This study
underlines the importance of understanding and thereby meeting patient goals .

x

Introduction
Herniation of the pelvic organs to or through the vaginal opening is found in up to
41% of women on exam. 1-3 Younger women have lower prevalence. Data from
the National Health and Nutrition Examination Survey22 showed that patients
from ages 20-39 had a prevalence of 1.6%, from 40-59 years 3.8%, from 60-79
years 3% and greater than 80 years had a prevalence of 4.1%. Although the
number of women who are symptomatic from their prolapse is lower,4,5 prolapse
is associated with significant deterioration of quality of life, including bowel,
bladder and vaginal complaints. Pelvic organ prolapse is not life threatening, but
can be life limiting. Women with prolapse are less likely to have fulfilling sexual
lives6 and are more likely to have urinary incontinence and bowel complaints in
addition to the anatomical distortion associated with pelvic organs protruding
from the vagina. 7-8
Treatment options for pelvic organ prolapse are limited to surgery, the use of a
pessary, or pelvic floor exercises. A pessary is a small plastic or silicone medical
device which is inserted into the vagina or rectum and held in place by the pelvic
floor musculature. Pelvic floor exercises are unlikely to correct advanced
prolapse and is not generally offered as curative treatment. 9 The only other nonsurgical management of prolapse are pessaries. Pessaries can be offered as a
first-line therapy for the management of pelvic organ prolapse symptoms
regardless of a patient's age or prolapse severity.10,11 Evidence on the use of
pessaries for prolapse treatment is limited; not all women can be successfully
fitted with a pessary and not all women continue to use their pessary in the long
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term.12 Likewise, surgical interventions vary in invasiveness and effectiveness.
Reoperation following surgery for incontinence or prolapse was 29% in one
epidemiologic study. 5 Most women with prolapse are eligible for either pessary
or surgical management, yet little is known about why patients choose one
therapy over the other. Individual treatment goals of patients may play a role in
why women choose surgical versus pessary treatment for their prolapse.
While a randomized trial comparing pessary to surgery for treatment of prolapse
would be an ideal method to compare the effectiveness of the two treatments,
more data are needed to investigate why women choose one treatment over
another. Previous direct comparisons of surgical and pessary management of
pelvic organ prolapse are sparse. In a cohort study13, surgically treated patients
had higher one year goal attainment and satisfaction scores compared to
patients treated with a pessary for treatment of a variety of pelvic floor
dysfunctions. Although overall goal attainment between pessary and surgery
groups was not different, surgically-managed patients had higher rates of
satisfaction at one year compared with non-surgically managed patients (76%
versus 37 %). Prior studies have not published baseline goal rating differences
between women treated with surgery versus those treated with pessary.
Other studies which evaluated treatment goal attainment have focused
either on women who choose surgery or who choose to use a pessary and do
not compare women who choose pessary versus surgery to treat their prolapse.
In these studies, the majority of women met their goals for treatment, regardless
of whether or not they choose surgical or pessary management. 6,7
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The primary objective of this study was to assess differences in goal setting of
women who choose surgery versus pessary management for treatment of
symptomatic prolapse among women eligible for both. We hypothesized that
women who choose pessary for treatment for symptomatic pelvic organ prolapse
have different self-selected goals for their treatment than women who choose
surgery for treatment of their pelvic organ prolapse. Better insight into personal
treatment goals may lead to improved patient counseling and decision making.
Methods
Study Participants
We recruited women presenting for care of pelvic organ prolapse to the
Urogynecology Clinic at the University of New Mexico. Women with prolapse
complaints complete the Pelvic Floor Distress Inventory14, an established
measure of distress for pelvic floor problems, including pelvic organ prolapse.
Women also underwent a pelvic exam to evaluate their prolapse using the Pelvic
Organ Prolapse Quantification exam (POPQ) 15. We recruited women who had
symptomatic stage 2 prolapse or greater based on the POPQ exam, and were
eligible for either surgical or pessary management (Table 1). All women gave
written documentation of their informed consent, and the study was approved by
the institutional review board of the University of New Mexico Health Sciences
Center. We chose a conservative difference of 0.4 points on a visual analog
scale in goal rating as the lowest difference that could potentially be clinically
significant. Based on this difference between groups, a sample size of 50
women per group was needed to provide 80% power at alpha =0.05 to detect
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Table 1 Study Inclusion Criteria
1. Symptomatic Stage 2 prolapse or greater and desire treatment
2. Attending surgeon assessment that patient able to undergo either surgical
or conservative management
3. Over the age of 18
4. Able to read and write English
5. Not pregnant

4

large effect size differences between groups. All data were analyzed in STATA
11.0.

Study Measures
In addition, patients completed the short form of the Pelvic Floor Distress
Inventory (PFDI-20) 14 (condition-specific, quality of life instrument developed for
women with all forms of pelvic floor disorders) the short form of the Pelvic Organ
Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12) 16 (the sexual
function questionnaire) and the Body Image Scale (BIS).17 (body image
assessment questionnaire). All the questionnaires except the last one are
completed by all clinic patients.
Patients listed up to three treatment goals and rated the importance of
each of these goals on a scale of 0 to 10. Counseling surgeons listed three
treatment goals that they thought the patients had for their treatment and rated
the importance of each goal on a scale of 0 to 10, without discussing or viewing
the goals written by the patient.
Patient goals were reviewed by six OB/GYN surgeons in both surgical and
pessary treatment and grouped into categories by type of goal. The expert group
initially utilized five treatment goal categories defined by prior authors including
symptom relief, quality of life, body image, emotional outcomes and others; goal
categories were modified as the analyses progressed by categorizing symptoms
into one group, quality of life related goals such as improved activity, continuing
with activities of daily living and combining the last three body image, emotional
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outcomes and other to form an ‘other’ category.18

Final categories of treatment

goals used in the present study were symptom relief, quality of life improvement
and other goals. The “symptom” category included patient goals related to
symptom abatement or management. Examples of goals in this category include
reduction in symptoms associated with prolapse, bowel or bladder complaints.
The “quality of life” category included goals for enhanced or improved sexual
health, social interaction and changes in the patient’s ability to participate in
social activities. The “other” category included more general statements
regarding overall happiness and well-being, emotional well-being, avoidance of
alternative therapy and body image changes.
Data Analysis
We used factorial ANOVA and TukeyHSD to compare mean rating scores for
each goals category between treatment groups. (Tables 5) The design of the
analysis was that of Treatment Group (Pessary vs. Surgery) (between groups) X
Goals (Symptom improvement vs. QOL improvement vs. Other goals) (within
subjects) to analyze the rated importance of each of these 3 categories of goals
by each patient. [N=50 per treatment group].
Results
Treatment Groups did not differ significantly in age, race/ethnicity, parity, body
mass index (BMI) and severity of disease. (Table 2) This sample of 100 women
was middle-aged and the majority were White. Responses to the PFDI-20 14,
BIS 16, and PISQ-12 15 were likewise not significantly different between
treatment groups. (Table 3)
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Table 2 Study Participant Characteristics
Characteristic

Age + SD (years)

Pessary

Surgery

(n=50)

(n=50)

62.3+ 10

61.2+ 8.7

Race (%)

p

0.86
0.85

White, Non-

58

60

Hispanic

4

2

African American

10

6

Native American

0

0

Asian American

28

32

BMI + SD

27.3 + 5.5

26.3 + 5

0.18

College graduate

36

16

0.08

Other

or higher (%)
Prolapse stage

0.72

(%)
Stage 1

2

0

Stage II

36

34

Stage III

58

60

Stage IV

4

6
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Table 3 Questionnaire responses to QOL questionnaires
Pessary

Surgery

p

(n=50)

(n=50)

PFDI-201 (SD)

117+ 60

117+ 69

0.86

PISQ-122 (SD)

21.1+ 10.1

17.6+ 7.4

0.15

BIS3 (SD)

7.7 + 5.7

7.2 + 6.7

0.60

1.

PFDI-20 : Pelvic Floor Distress Inventory -20

2.

PISQ-12 : Pelvic Organ Prolapse / Urinary Incontinence Sexual

Questionnaire (PISQ-12)
3.

BIS : Body Image Scale
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Initial review of patient goals were grouped into the five previous categories
defined during study design with significant overlap observed between treatment
goal groups. We then further combined treatment goal groups so that goals were
ultimately categorized into ” symptoms”, “quality of life” and “other” as described
earlier.
Patients’ mean ratings of goal importance did not differ significantly between
surgery and pessary groups for the symptoms and quality of life categories
(Table 4). However, groups did vary in the ratings of the “other” category with the
surgery group rating this “other goals” higher than did the pessary group. A 2
way 2 * 3 mixed model repeated ANOVA was performed for Treatment group
(independent variable) and goal ratings (dependent variable) for the three
categories. 50 patients chose pessary and 50 patients chose surgery. Patients
then rated the importance of Goal 1 (Symptoms), Goal 2 (Quality of life) and Goal
3 (Other) which constituted the repeated measures on the ANOVA. We wanted
to assess the effect of group i.e. pessary Vs surgery on goal ratings, assessed if
there was an interaction between goal categories and treatment groups and also
the effect of goals and treatment groups separately. This analysis shows a main
effect for goal importance: patients rate “other goals” as significant less
important than either goals of “symptom” reduction” or the presence of a main
effect for goal type i.e.1, 2 or 3 (the repeated factor). The interaction between
the goals and treatment groups was not significant (p = 0.49). In order to
analyze this further, the means are plotted and show that while there is an
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Table 4 Mean goal ratings of surgery and pessary patients
Category of goal

Pessary group

Surgery group

Cohen’s d

Symptoms (SD)

8.76 (0.21)

8.68 (0.21)

0.18

Quality of life (SD)

8.64 (0.13)

8.95 (0.13)

0.31

Other (SD)

7.59 (0.22)

7.74 (0.22)

0.02
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interaction between Goal 1 and Goal 2, there is no interaction of Goal 3 with
either indicating that perhaps there is a significant difference in Goal 3 within the
subjects. (Figure1). Groups 1 and 2 show a similar pattern but group 3 shows a
different pattern indicating that pessary patients perhaps valued the other
category far less than the surgery patients. Between subject effects showed no
significant effect for the group i.e. pessary or surgery patient group (p = 0.508)
and therefore the choice of pessary or surgery per se did not influence goal
ratings (Table 5).
Discussion
Among women with symptomatic prolapse, goal rating of the importance of
symptom reduction and quality of life improvement did not differ between those
who chose surgery and those who chose pessary. However, women who chose
surgery were more likely to rate “other” goals more highly than women who
chose pessary. This finding supports the overall conclusion that women who
choose a pessary for treatment of prolapse have similar symptom relief and
quality of life goals to women who choose surgery. The difference in goal setting
between groups was on specifics regarding changes in body image, avoiding
alternative therapies or expectations from treatment.
Patient goals may provide insight into what motivates patients to choose one
treatment over another and may prove a method by which to directly compare
surgical to non-surgical interventions. Achieving patient goals improves patient
satisfaction with treatment. 13 While goal attainment following treatment is
important, goal setting prior to treatment is may provide better insight into why
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Figure 1 Mean ratings of treatment goal importance of pessary vs. surgery
patients
10

Mean
Goal
Rating

5

0

Surgery group

Pessary group
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Table 5 ANOVA Summary Table of Goals and Pessary vs Surgery Patients
Between and Within Subject Effects

Source
Pessary vs. surgery

df
1

SS

MS

2.407

2.407

535.433

5.464

159.703

Goals * pessVssurg 1.887
Error

190.411

Total

194.241

Error

98

Total

99

Goals (within)

1.943

F

P

0.440

0.508

82.196

29.823

0.000

3.843

1.978

0.718

0.485

524.787

2.756
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women choose one therapy over another.
Previous direct comparisons of surgical and pessary management of pelvic
organ prolapse are sparse. No data compare goal setting between women who
choose conservative management with pessary versus those who choose
surgical management for symptomatic pelvic organ prolapse, although a prior
single study compared goal attainment following treatment between groups.
Srikrishna et al validated the PGI-I 20 questionnaire for pelvic organ prolapse
and studied patient goal achievement 2 years after surgery for prolapse and
urinary incontinence. 21 Patients were asked if they met their goals adequately.
The mean patient goal achievement at 2 years was 85.1%.
Elkadry et al 5 undertook a study to assess goals of patients undergoing pelvic
reconstructive surgery. Established measures of patient global impression of
severity (PGI-S) 5 and patient global impression of improvement (PGI-I) 20 were
used to assess baseline symptom severity and improvement after surgery.
Seventy-five percent of women reported that they met all or most of their goals,
4% met half, 12% met less than half and 9% met none of their goals. Komesu et
al7 studied women who were using a pessary to treat either prolapse or
incontinence and found that women who continued using their pessary were
more likely to attain goals compared to those who quit using their pessary. In
that study, each 1-point improvement in the PGI-I scale was associated with a
4.6 fold increase in likelihood of pessary continuation. These studies look at
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surgery or pessary separately and also have assessed goal achievement rather
than goal setting.
Weaknesses of the study were that the patients listed only three of their goals
independently. It may have been possible that the patients may have had more
goals and therefore more differences between the two groups which has not
been assessed. The categorization of goals was made by the ‘expert’ surgeons
and not the patients and is therefore subject to possible bias (i.e. it is the surgeon
perception of patient goals which may not have been completely accurate). The
counseling for the choice of pessary vs. surgery was not standardized and may
have been subject to individual provider bias. Further categorization of goals to
elicit the precise differences between the groups could have been helpful. In
addition, having patients rate the importance of a comprehensive list of all
potential patient goals may add insight into patient goal setting and achievement.
And, the design did not assess goals prior to consultation when providers may
have influenced patients goal ratings, nor did it assess patient goals after
treatment to detect possible changes in goals as a function of treatment
outcomes.
The strengths of the study are that this is novel to assess the differences
between the two groups of pessary and surgery patients for treatment of
prolapse. We recruited patients that chose their treatment so we could assess
normal goal setting independently what goals might be if patients were
randomized to treatment. Had the patients been randomized the reasons for their
choice of pessary or surgery would not be apparent. The patients in the different
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treatment groups in the present study have similar baseline characteristics and
are thus comparable.
Future directions for further studies should also include which “other” categories
lead to the differences between the pessary and surgery groups. Treatment
choices may be correlated with treatment goals and this needs to be studied
further.
Conclusion
Patients that choose surgery compared to those that choose pessary differ in the
goal categories consisting of overall happiness and well-being, avoidance of
alternative therapy and body image changes. The choice of pessary or surgery
itself does not appear to be related to symptoms, severity of disease or goals
related to quality of life.
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